Comparison of physician-managed lipid-lowering care in patients with coronary heart disease in two time periods (1994 and 1999)

American Journal of Cardiology

Volumn 88, Issue 12, 2001, Pages 1417-1419

  Smith, Donald A ^a,b   Harnick, David ^a   Kilaru, Ravi ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE BESYLATE; ANTILIPEMIC AGENT; ATORVASTATIN; BILE ACID; FIBRIC ACID DERIVATIVE; LIPID; SIMVASTATIN; STATIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICIAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTILIPEMIC AGENTS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; TREATMENT OUTCOME;

EID: 0035893371     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02124-5     Document Type: Article

References (13)

1. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease
2. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
3. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
4. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
5. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease
6. Lipid management in a private cardiology practice (the Midwest Heart Experience)
7. Nurse case management compared with usual physician care for lipid management following revascularization
8. Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: Importance of diet, exercise, weight control, and drug therapy
9. A case-management system for coronary risk factor modification after acute myocardial infarction
10. Lipid lowering in a multidisciplinary clinic compared with primary physician management
11. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers
12. Lipid lowering therapy in CAD patients at academic medical centers: Undertreatment and evidence of a gender gap
13. Clinical reality of coronary prevention guidelines: A comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events